Aesica is a trusted and well-established supplier of Active Pharmaceutical Ingredients (APIs), Formulations and Custom Synthesis solutions to the global pharmaceutical and biotechnology industries. The company's products are the pharmacologically active ingredients that provide the therapeutic effects within medications and its customers include top ten pharmaceutical companies, leading generics manufacturers and new emerging companies across the major pharmaceutical markets: Japan, Europe and North America. 95% of Aesica's products are exported outside the UK.
Aesica's headquarters are located on a 90-acre site in Cramlington, Northumberland. The business has its own technical development capability and a kilo lab for early phase development. Its manufacturing facilities comprise of five computer controlled multi-product plants working to cGMP standards, manufacturing in campaigns from 50kg to 100mt.
Aesica is committed to delivering value to its customers and shareholders by remaining flexible and responsive to change, meeting customers' needs, and exceeding their expectations. The company delivers value through the expertise of its technical development team, the excellence of its state-of-the-art manufacturing facilities and a commitment to provide the best customer service in the industry.
